FNDC5 and gestational diabetes: Similarly, serum miR-377-3p was elevated in patients with GDM, and miR-377-3p was found to directly target FNDC5 in a cell model, promoting GDM by inhibiting cell growth reconstitution and increasing the rate of apoptosis [72].